Page last updated: 2024-08-26

norcantharidin and Cancer of Prostate

norcantharidin has been researched along with Cancer of Prostate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, YS; Chiou, HL; Hsieh, YH; Hui, SC; Lee, CH; Lin, CY; Wu, MH1
Chen, CM; Cheng, CW; Hsieh, YH; Lee, CH; Lin, CL1
Gao, J; Hu, Z; Li, H; Li, J; Mo, L; Shi, X; Wei, L; Zhang, X; Zheng, D1
He, PJ; Shao, CL; Shen, B1
Chou, CY; Hu, DN; Kao, YH; Lin, IC; Wu, YC; Yang, PY1

Other Studies

5 other study(ies) available for norcantharidin and Cancer of Prostate

ArticleYear
Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression.
    Environmental toxicology, 2021, Volume: 36, Issue:11

    Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sirtuins

2021
Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
    Biochimica et biophysica acta. Molecular cell research, 2017, Volume: 1864, Issue:10

    Topics: Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Forkhead Transcription Factors; Humans; Male; Mice; MicroRNAs; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Oncogene Protein v-akt; Prostatic Neoplasms; Transcription Factors; Xenograft Model Antitumor Assays

2017
Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.
    Cancer science, 2018, Volume: 109, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cancer Vaccines; Cell Proliferation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphocytes, Tumor-Infiltrating; Male; Mice; Prostatic Neoplasms; T-Lymphocytes, Regulatory

2018
Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Situ Nick-End Labeling; Male; Membrane Potential, Mitochondrial; Micronucleus Tests; Mitochondria; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Reactive Oxygen Species; Superoxide Dismutase

2013
Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:5

    Topics: Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Line, Tumor; Cytochromes c; fas Receptor; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF Receptor-Associated Death Domain Protein; Up-Regulation

2016